日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mitochondrial DNA methylation in metabolic associated fatty liver disease

代谢相关脂肪肝疾病中的线粒体 DNA 甲基化

Archibold Mposhi, Fabian Cortés-Mancera, Janette Heegsma, Vincent E de Meijer, Bart van de Sluis, Svenja Sydor, Lars P Bechmann, Claudia Theys, Peter de Rijk, Tim De Pooter, Wim Vanden Berghe, İkbal Agah İnce, Klaas Nico Faber, Marianne G Rots

Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics

利用粪便宏蛋白质组学发现患有或不患有肝细胞癌的非酒精性脂肪性肝炎患者的生物标志物

Svenja Sydor, Christian Dandyk, Johannes Schwerdt, Paul Manka, Dirk Benndorf, Theresa Lehmann, Kay Schallert, Maximilian Wolf, Udo Reichl, Ali Canbay, Lars P Bechmann, Robert Heyer

Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)

脂肪:质还是量?什么对代谢性脂肪肝病 (MAFLD) 的进展最重要

Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Johanna Reissing, Tony Bruns, Carlos Sanz-García, Svenja Sydor, Lars P Bechmann, Eva Maranillo, José Ramón Sañudo, María Teresa Vázquez, Arantza Lamas-Paz, Laura Morán, Marina S Mazariegos, Andreea Ciu

Simultaneous Induction of Glycolysis and Oxidative Phosphorylation during Activation of Hepatic Stellate Cells Reveals Novel Mitochondrial Targets to Treat Liver Fibrosis

肝星状细胞激活过程中同时诱导糖酵解和氧化磷酸化揭示了治疗肝纤维化的新型线粒体靶点

Natalia Smith-Cortinez, Karen van Eunen, Janette Heegsma, Sandra Alejandra Serna-Salas, Svenja Sydor, Lars P Bechmann, Han Moshage, Barbara M Bakker, Klaas Nico Faber